Short-Term and Long-Term Outcomes of Infliximab and Tacrolimus Treatment for Moderate to Severe Ulcerative Colitis: Retrospective Observational Study.

Takafumi Otsuka,Makoto Ooi, Kazutoshi Tobimatsu, Chika Wakahara,Daisuke Watanabe,Soichiro Adachi,Eiichiro Yasutomi, Haruka Yamairi,Yuna Ku,Masaru Yoshida,Namiko Hoshi,Yuzo Kodama

The Kobe journal of medical sciences（2018）

引用 28|浏览1

暂无评分

摘要

This study indicates that IFX and TAC produce similar short-term outcomes in UC patients, but IFX produces better long-term outcomes than TAC especially with avoidance of colectomy. Our data suggest that IFX therapy may be prioritized over TAC for the treatment of moderate to severe UC.

查看译文

关键词

Infliximab,Tacrolimus,Ulcerative colitis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要